COMMENTARY

• COMMENTARY／Reform of Ethical Drug Distribution Practices
  September 1, 2008

• COMMENTARY／Gov't to Cut Social Security Spending by \220 Bil by Promoting Use of Generics
  August 25, 2008

• COMMENTARY／Development Race for RNAi Therapeutics Heating Up in Japan
  August 4, 2008

• COMMENTARY 4 articles
  July 28, 2008

• COMMENTARY／Industry Needs More Creative Thinking: NHI Pricing System Reform
  July 21, 2008

• COMMENTARY／Will Fiscal Rehabilitation Policy Be Maintained?
  July 7, 2008

• COMMENTARY／Daiichi Sankyo Surprises the World by Announcing Acquisition of Ranbaxy
  June 30, 2008

• Pharmaceutical Partnerships in Japan for Regulatory and Commercial Success
  June 30, 2008

• COMMENTARY 4 articles
  June 9, 2008

• COMMENTARY／Shaking Pharmaceutical Administration System
  May 19, 2008

• COMMENTARY／Personnel Strategy -New Graduates or Work-Ready MRs?
  April 21, 2008

• COMMENTARY／Industry-Academia Cooperation Essential for Practical Use of iPS Cells
  April 21, 2008

• COMMENTARY／Improvement of Drug Distribution Business Practices Goes into Crucial Stretch
  April 14, 2008

• COMMENTARY／Mr Kodama Owes His Sweeping Victory to Members' Desire for Change: JPA
  March 31, 2008

• COMMENTARY／Most Mainstay Products Avoid Deep Price Cuts in FY2008 NHI Price Revision
  March 31, 2008

• Methodologic Issues in the Clinical Trial Study of Depression
  March 24, 2008

• COMMENTARY／Major Wholesalers vs Hansha Competition to Intensify on Growing Market for Generics
  March 3, 2008

• COMMENTARY／Preparations for New OTC Drug Marketing System Enter Final Stage
  March 3, 2008

• COMMENTARY／Japan Needs to Create Attractive "Stadium for Drug Discovery" and Invite Top-Level Players
  February 25, 2008

• Current New Drug Development in the Japanese Pharmaceutical Industry（1）
  February 11, 2008

ページ